Product Introduction:
Voglikem M SR Tablet combines Voglibose, an alpha-glucosidase inhibitor that delays carbohydrate absorption, and Metformin SR (sustained release), which lowers hepatic glucose production and improves insulin sensitivity, helping in effective blood sugar control.
Uses:
-
Management of type 2 diabetes mellitus
-
Control of post-meal blood glucose spikes
-
Improving overall glycemic control with sustained release action
Benefits:
-
Provides prolonged blood sugar control due to sustained-release Metformin
-
Reduces postprandial hyperglycemia
-
Enhances insulin sensitivity
-
Lowers risk of diabetes-related complications
Composition:
-
Voglibose 0.3 mg
-
Metformin Hydrochloride Extended Release 500 mg
Side Effects:
Common side effects may include:
-
Gastrointestinal symptoms such as nausea, diarrhea, and abdominal discomfort
-
Headache
-
Dizziness
-
Rare risk of lactic acidosis (seek immediate medical attention if symptoms occur)
Safety Advice:
-
Take with meals to minimize gastrointestinal discomfort
-
Regularly monitor blood glucose levels
-
Avoid alcohol consumption during treatment
-
Not recommended for patients with severe kidney or liver disease
-
Inform your healthcare provider about other medications before starting treatment
